Literature DB >> 24400836

Probing the N-terminal β-sheet conversion in the crystal structure of the human prion protein bound to a nanobody.

Romany N N Abskharon1, Gabriele Giachin, Alexandre Wohlkonig, Sameh H Soror, Els Pardon, Giuseppe Legname, Jan Steyaert.   

Abstract

Prions are fatal neurodegenerative transmissible agents causing several incurable illnesses in humans and animals. Prion diseases are caused by the structural conversion of the cellular prion protein, PrP(C), into its misfolded oligomeric form, known as prion or PrP(Sc). The canonical human PrP(C) (HuPrP) fold features an unstructured N-terminal part (residues 23-124) and a well-defined C-terminal globular domain (residues 125-231). Compelling evidence indicates that an evolutionary N-terminal conserved motif AGAAAAGA (residues 113-120) plays an important role in the conversion to PrP(Sc). The intrinsic flexibility of the N-terminal has hampered efforts to obtain detailed atomic information on the structural features of this palindromic region. In this study, we crystallized the full-length HuPrP in complex with a nanobody (Nb484) that inhibits prion propagation. In the complex, the prion protein is unstructured from residue 23 to 116. The palindromic motif adopts a stable and fully extended configuration to form a three-stranded antiparallel β-sheet with the β1 and β2 strands, demonstrating that the full-length HuPrP(C) can adopt a more elaborate β0-β1-α1-β2-α2-α3 structural organization than the canonical β1-α1-β2-α2-α3 prion-like fold. From this structure, it appears that the palindromic motif mediates β-enrichment in the PrP(C) monomer as one of the early events in the conversion of PrP(C) into PrP(Sc).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24400836     DOI: 10.1021/ja407527p

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  34 in total

Review 1.  Nanobodies as Probes for Protein Dynamics in Vitro and in Cells.

Authors:  Oleg Y Dmitriev; Svetlana Lutsenko; Serge Muyldermans
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

2.  Simulations of membrane-bound diglycosylated human prion protein reveal potential protective mechanisms against misfolding.

Authors:  Chin Jung Cheng; Heidi Koldsø; Marc W Van der Kamp; Birgit Schiøtt; Valerie Daggett
Journal:  J Neurochem       Date:  2017-05-22       Impact factor: 5.372

3.  Liquid and Hydrogel Phases of PrPC Linked to Conformation Shifts and Triggered by Alzheimer's Amyloid-β Oligomers.

Authors:  Mikhail A Kostylev; Marcus D Tuttle; Suho Lee; Lauren E Klein; Hideyuki Takahashi; Timothy O Cox; Erik C Gunther; Kurt W Zilm; Stephen M Strittmatter
Journal:  Mol Cell       Date:  2018-10-25       Impact factor: 17.970

4.  Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease.

Authors:  Romany Abskharon; Paul M Seidler; Michael R Sawaya; Duilio Cascio; Tianxiao P Yang; Stephan Philipp; Christopher Kazu Williams; Kathy L Newell; Bernardino Ghetti; Michael A DeTure; Dennis W Dickson; Harry V Vinters; Philip L Felgner; Rie Nakajima; Charles G Glabe; David S Eisenberg
Journal:  J Biol Chem       Date:  2020-06-03       Impact factor: 5.157

5.  Acid-induced molten globule state of a prion protein: crucial role of Strand 1-Helix 1-Strand 2 segment.

Authors:  Ryo P Honda; Kei-Ichi Yamaguchi; Kazuo Kuwata
Journal:  J Biol Chem       Date:  2014-09-12       Impact factor: 5.157

Review 6.  Exploring cellular biochemistry with nanobodies.

Authors:  Ross W Cheloha; Thibault J Harmand; Charlotte Wijne; Thomas U Schwartz; Hidde L Ploegh
Journal:  J Biol Chem       Date:  2020-08-31       Impact factor: 5.157

Review 7.  Transition of the prion protein from a structured cellular form (PrPC ) to the infectious scrapie agent (PrPSc ).

Authors:  Pravas K Baral; Jiang Yin; Adriano Aguzzi; Michael N G James
Journal:  Protein Sci       Date:  2019-10-25       Impact factor: 6.725

8.  Novel quaternary structures of the human prion protein globular domain.

Authors:  Leandro Oliveira Bortot; Victor Lopes Rangel; Francesca A Pavlovici; Kamel El Omari; Armin Wagner; Jose Brandao-Neto; Romain Talon; Frank von Delft; Andrew G Reidenbach; Sonia M Vallabh; Eric Vallabh Minikel; Stuart Schreiber; Maria Cristina Nonato
Journal:  Biochimie       Date:  2021-09-10       Impact factor: 4.079

Review 9.  Conformational selection in amyloid-based immunotherapy: Survey of crystal structures of antibody-amyloid complexes.

Authors:  Buyong Ma; Jun Zhao; Ruth Nussinov
Journal:  Biochim Biophys Acta       Date:  2016-06-03

Review 10.  Nanobodies to Study G Protein-Coupled Receptor Structure and Function.

Authors:  Aashish Manglik; Brian K Kobilka; Jan Steyaert
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-12-07       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.